PGD and cervical cancer: Recent work suggested that 6-phosphogluconate dehydrogenase (6PGD), the key enzyme of oxidative pentose phosphate pathway (PPP), could act as a potential therapeutic target to enhance chemosensitivity in cervical cancer [46].